AL
CPRX icon

AJO LP’s Catalyst Pharmaceutical CPRX Stock Holding History

AJO LP’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31,991
Closed -$147K – 711
2020
Q2 		$147K Sell
31,991
-7,097
-18% -$31.9K ﹤0.01% 602
2020
Q1 		$150K Buy
+39,088
New +$160K ﹤0.01% 580
2018
Q2 		– Sell
-234,768
Closed -$561K – 654
2018
Q1 		$561K Sell
234,768
-161,861
-41% -$538K ﹤0.01% 550
2017
Q4 		$1.55M Sell
396,629
-369,604
-48% -$1.22M 0.01% 450
2017
Q3 		$1.93M Buy
766,233
+107,259
+16% +$294K 0.01% 425
2017
Q2 		$1.82M Buy
+658,974
New +$1.38M 0.01% 431

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AJO LP's CPRX Position: Q3 2020 in Review

AJO LP sold out of Catalyst Pharmaceutical (CPRX) in Q3 2020, closing a stake of 31,991 shares — an estimated $147K sold.

AJO LP first reported a position in CPRX in Q2 2017 and held it in 6 quarters. The position peaked at $1.93M in Q3 2017. 142 funds tracked by Wall St. Rank hold CPRX as of Q3 2020.

  • AJO LP reported no remaining Catalyst Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • AJO LP sold 31,991 Catalyst Pharmaceutical shares in Q3 2020, an estimated $147K.
  • AJO LP first reported a position in Catalyst Pharmaceutical in Q2 2017 and held it in 6 quarters.
  • AJO LP's Catalyst Pharmaceutical position peaked at $1.93M in Q3 2017.
  • 142 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2020.

Based on AJO LP's 13F filing for Q3 2020, filed 10 Nov 2020.